- Home
- MSEX vs SGP Comparison
MSEX vs SGP Comparison
Compare MSEX & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MSEX | SGP |
|---|---|---|
| Founded | 1897 | 2019 |
| Country | United States | United States |
| Employees | 395 | N/A |
| Industry | Water Supply | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 932.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MSEX | SGP |
|---|---|---|
| Price | $52.41 | $21.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $61.33 | $45.00 |
| AVG Volume (30 Days) | ★ 95.0K | 49.9K |
| Earning Date | 04-30-2026 | 05-15-2026 |
| Dividend Yield | ★ 2.77% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.60 | N/A |
| Revenue Next Year | $10.94 | N/A |
| P/E Ratio | $22.68 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $44.94 | $20.15 |
| 52 Week High | $62.18 | $30.56 |
Technical Indicators
Market Signals| Indicator | MSEX | SGP |
|---|---|---|
| Relative Strength Index (RSI) | 53.89 | 36.44 |
| Support Level | $51.83 | N/A |
| Resistance Level | $54.83 | $26.29 |
| Average True Range (ATR) | 1.12 | 1.54 |
| MACD | 0.08 | -0.28 |
| Stochastic Oscillator | 82.85 | 2.59 |
Price Performance
Historical ComparisonAbout MSEX Middlesex Water Company
Middlesex Water Co owns and operates regulated water utility and wastewater systems in the U.S. The company has two operating segments, Regulated and Non-Regulated. The regulated business includes collecting and distributing water to residential, commercial, industrial, and fire protection consumers. The non-regulated business includes contract services for the operation of private water and wastewater systems. The majority of the company's revenue is derived from the Regulated segment and from residential customers.
About SGP SpyGlass Pharma Inc. Common Stock
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.